申请人:Bebbington David
公开号:US20090312543A1
公开(公告)日:2009-12-17
This invention describes novel pyrazole compounds of formula IIIa:
wherein R
1
is T-Ring D, wherein Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; R
x
, R
y
, R
2
, and R
2′
are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
本发明描述了式IIIa的新型吡唑化合物:
其中R1是T-Ring D,其中环D是5-7成员单环或8-10成员双环,选自芳基,杂芳基,杂环基或碳环基;Rx,Ry,R2和R2'如说明书所述。该化合物可用作蛋白激酶抑制剂,特别是用于抑制Aurora-2和GSK-3,治疗癌症,糖尿病和阿尔茨海默病等疾病。